[an error occurred while processing this directive]
BBC News
watch One-Minute World News
Last Updated: Friday, 4 March, 2005, 21:37 GMT
Glaxo sees two drugs seized in US
Advertisement for GSK anti-depressant Paxil
GSK's anti-depressant Paxil is one of the two drugs seized
The US Food and Drug Administration (FDA) has seized batches of two GlaxoSmithKline drugs, because of concerns over manufacturing quality.

In a statement, the FDA said the two drugs affected were diabetes tablets Avandamet and the slow-release anti-depressant Paxil CR.

The FDA said the two products failed to meet standards for safety, strength, quality and purity.

Yet it added that it did not believe they posed a health hazard.

Patients who are taking either medication have been advised to continue to do so, but also talk to their doctor about the possibility of using alternative products until the manufacturing problems are corrected.

Shares down

The FDA said that the Paxil CR tablets could split apart, leaving a person with part of a tablet that did not contain the active ingredient.

And the Avandamet tablets did not have an accurate dose of their active ingredient, it said.

"FDA and the Department of Justice will not allow drug manufacturers to ignore our high public health standards for drug manufacturing," said John Taylor, FDA associate commissioner for regulatory affairs.

Glaxo said it was working to resolve manufacturing problems as quickly as possible.

Yet it added that both drugs would be in short supply in the United States in the short term. UK-based Glaxo saw its shares closed down 2.2% in London following the FDA announcement.

A spokesman for the company said it was too early to assess the financial impact of the seizures.


SEE ALSO:
GSK aims to stop Aids profiteers
21 Feb 05 |  Business
Glaxo aims high after profit fall
10 Feb 05 |  Business
Glaxo settles New York drug suit
27 Aug 04 |  Business
Glaxo releases drug trials on web
18 Jun 04 |  Business
Glaxo responds to Aids drugs call
10 Dec 03 |  Business


RELATED INTERNET LINKS:
The BBC is not responsible for the content of external internet sites


PRODUCTS AND SERVICES

News Front Page | Africa | Americas | Asia-Pacific | Europe | Middle East | South Asia
UK | Business | Entertainment | Science/Nature | Technology | Health
Have Your Say | In Pictures | Week at a Glance | Country Profiles | In Depth | Programmes
Americas Africa Europe Middle East South Asia Asia Pacific